Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05343585 · ClinicalTrials.gov registry record · NA
Validity of an AI-based Program to Identify Foods and Estimate Food Portion Size
A NA study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT05343585: Completed NA study, sponsored by Pennington Biomedical Research Center.
NCT05343585 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05343585, a NA study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to test the accuracy of the Nutrition Artificial Intelligence in the Openfit app during meals in a controlled laboratory setting
Primary Outcome
Agreement surrounding identification of food and beverages provided compared with known identification, at the item level, and across all items where identification is determined by: 1) Nutrition AI without correction (automated), 2) Nutrition AI with user correction (semi-automated) For a food identified through the Nutrition AI to be considered an exact food match, the name of the food identified must match or be a close match to the food served. For example, a fruit cocktail identified as a
Interventions
- DEVICE PortionSize AI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-04-27 |
| Est. Completion | 2022-06-03 |
| Phase | NA |
What the finished NCT05343585 record still lists
NCT05343585 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which PortionSize AI is the first listed.
NCT05343585 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05343585 about?
NCT05343585 is a clinical study titled "Validity of an AI-based Program to Identify Foods and Estimate Food Portion Size". The purpose of this study is to test the accuracy of the Nutrition Artificial Intelligence in the Openfit app during meals in a controlled laboratory setting
What is the current status of trial NCT05343585?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2022-04-27. Estimated completion is 2022-06-03.
What interventions are being tested in trial NCT05343585?
The interventions under investigation include: PortionSize AI (DEVICE).
Who is sponsoring clinical trial NCT05343585?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05343585's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI